BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30158413)

  • 1. [Multicentral Questionnaire Results for Consciousness of Medical Personnel on Chemotherapy for Gastric and Colorectal Cancer].
    Sasaki S; Hiraiwa T; Ishimaru M; Funahashi K; Koike J; Seto Y; Yamashita H; Furushima K; Sakai K
    Gan To Kagaku Ryoho; 2018 Aug; 45(8):1171-1176. PubMed ID: 30158413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in attitude toward adjuvant chemotherapy between colorectal cancer survivors and the medical staff of Japanese hospitals.
    Narita Y; Taniguchi H; Komori K; Kimura K; Kinoshita T; Komori A; Nomura M; Kadowaki S; Takahari D; Ura T; Andoh M; Muro K
    Int J Clin Oncol; 2015 Aug; 20(4):755-60. PubMed ID: 25424249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in cancer patients treated by chemotherapy.
    Scieszka M; Zielinski M; Machalski M; Herman ZS
    Neoplasma; 2000; 47(6):396-9. PubMed ID: 11263865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of pre-operative administration of TS-1 in patients with advanced gastric or colorectal cancer--estimation of pathological effectiveness for postoperative adjuvant chemotherapy with TS-1].
    Nakano K; Koizumi H; Okugawa K; Nakamura K; Osaka Y; Tsuchiya K; Sako H; Tanabe S; Nakane Y
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):329-33. PubMed ID: 15791815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endostar combined with chemotherapy for treatment of metastatic colorectal and gastric cancer: a pilot study.
    Zhou JF; Bai CM; Wang YZ; Li XY; Cheng YJ; Chen SC
    Chin Med J (Engl); 2011 Dec; 124(24):4299-303. PubMed ID: 22340403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' perceptions of how healthcare providers communicate with them and their families following a diagnosis of colorectal cancer and undergoing chemotherapy treatment.
    McCarthy B
    Eur J Oncol Nurs; 2014 Oct; 18(5):452-8. PubMed ID: 24954770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functioning of people with colorectal cancer during chemotherapy. Demographic and clinical determinants of quality of life of patients with colorectal cancer receiving chemotherapy. Pilot study.
    Goździewicz B; Strugała M; Talarska D; Stanisławska J; Bączyk G
    Eur J Cancer Care (Engl); 2017 May; 26(3):. PubMed ID: 28026057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry.
    Mols F; Beijers T; Lemmens V; van den Hurk CJ; Vreugdenhil G; van de Poll-Franse LV
    J Clin Oncol; 2013 Jul; 31(21):2699-707. PubMed ID: 23775951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study of enhancement of cisplatin activity by high dose cytarabine in advanced gastric and colorectal (G3/G4) cancer.
    Popov I; Jelić S; Radulović S; Tomasević Z
    Neoplasma; 1996; 43(4):221-4. PubMed ID: 8931744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A questionnaire survey on QOL and toxicity in colorectal cancer survivors who received adjuvant chemotherapy].
    Taniguchi H; Narita Y; Komori K; Kimura K; Kinoshita T; Komori A; Uegaki S; Nomura M; Nitta S; Yamaguchi K; Kadowaki S; Takahari D; Ura T; Andoh M; Muro K
    Gan To Kagaku Ryoho; 2015 Apr; 42(4):457-61. PubMed ID: 25963692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of FOLFIRI Regimen in Elderly Versus Nonelderly Patients with Metastatic Colorectal or Gastric Cancer.
    Kim JW; Lee KW; Kim KP; Lee JH; Hong YS; Kim JE; Kim SY; Park SR; Nam BH; Cho SH; Chung IJ; Park YS; Oh HS; Lee MA; Kang HJ; Park YI; Song EK; Han HS; Lee KT; Shin DB; Kang JH; Zang DY; Kim JH; Kim TW
    Oncologist; 2017 Mar; 22(3):293-303. PubMed ID: 28209749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Questionnaire survey on patients receiving scheduled inpatient chemotherapy clarifies the issues of outpatient chemotherapy for advanced or recurrent colorectal cancer].
    Arakawa Y; Sakuyama T; Ichiba T; Inoue D; Kobayashi T; Aiba K
    Gan To Kagaku Ryoho; 2007 Dec; 34 Suppl 2():245-7. PubMed ID: 20443276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in patients with advanced gastric cancer treated with second-line chemotherapy.
    Park SH; Lee WK; Chung M; Bang SM; Cho EK; Lee JH; Shin DB
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):289-94. PubMed ID: 16010588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Team-based medical care can improve tailor made chemotherapy for colorectal cancer].
    Muneoka K; Shirai Y; Sasaki M; Kanda J; Asakura T; Wakabayashi H; Toshima M; Hatakeyama K
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1883-7. PubMed ID: 19011336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of adjuvant and neoadjuvant chemotherapy in treatment of stomach carcinoma].
    Ausch C; Rosen HR; Schiessel R
    Wien Klin Wochenschr; 1996; 108(16):496-504. PubMed ID: 8967093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of postoperative early chemotherapy for locoregional lymph node metastases of gastric and colorectal cancer.
    Morimoto H; Tanigawa N
    Oncology; 1991; 48(3):210-4. PubMed ID: 2023699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.
    Tsuruta A; Yamashita K; Tanioka H; Tsuji A; Inukai M; Yamakawa T; Yamatsuji T; Yoshimitsu M; Toyota K; Yamano T; Nagasaka T; Okajima M
    Drug Des Devel Ther; 2016; 10():3827-3835. PubMed ID: 27920498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of 5'-DFUR treatment as postoperative adjuvant chemotherapy for stomach and colorectal cancer. Tokai GATS Group (pilot study)].
    Yamaguchi A; Maeda A; Hachisuka K; Yura J; Honda K; Honda H; Yoshizaki S; Tsuruga N; Nakazato H
    Gan To Kagaku Ryoho; 1994 Apr; 21(5):621-6. PubMed ID: 8154887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Excretion Management During Colorectal Cancer Chemotherapy].
    Koyama T; Kagawa Y; Shimokawa F; Funakoshi S; Nanbara M; Naito A; Hirooka T; Tachihara A; Watanabe M; Kano S; Takeda Y; Tamura S; Kato T; Ikeue H
    Gan To Kagaku Ryoho; 2016 Aug; 43(8):989-93. PubMed ID: 27539042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.